20 Neisseria gonorrhoeae. Resistance to first-line empirical monotherapy has emerged, so 21 robust methods are needed to appropriately evaluate the activity of existing and novel 22 antimicrobials against the bacterium. Pharmacodynamic functions, which describe the 23 relationship between the concentration of antimicrobials and the bacterial net growth 24 rate, provide more detailed information than the MIC only. In this study, a novel 25 standardized in vitro time-kill curve assay was developed. The assay was validated using 26 five World Health Organization N. gonorrhoeae reference strains and various 27 concentrations of ciprofloxacin, and then the activity of nine antimicrobials with different 28 target mechanisms were examined against a highly susceptible clinical wild type isolate 29 (cultured in 1964). From the time-kill curves, the bacterial net growth rates at each 30 antimicrobial concentration were estimated. Finally, a pharmacodynamic function was 31 fitted to the data, resulting in four parameters that describe the pharmacodynamic 32 properties of each antimicrobial. Ciprofloxacin resistance determinants shifted the 33 pharmacodynamic MIC (zMIC) and attenuated the bactericidal effect at antimicrobial 34 concentrations above the zMIC. Ciprofloxacin, spectinomycin and gentamicin had the 35 strongest bactericidal effect during the first six hours of the assay. Only tetracycline and 36 chloramphenicol showed a purely bacteriostatic effect. The pharmacodynamic functions 37 differed between antimicrobials, showing that the effect of the drugs at concentrations 38 below and above the MIC vary widely. In conclusion, N. gonorrhoeae time-kill curve 39 experiments analyzed with pharmacodynamic functions have potential for in vitro 40 evaluation of new and existing antimicrobials and dosing strategies to treat gonorrhea.
antimicrobial monotherapy, ceftriaxone, was firstly described in 2009 (1, 2) . Currently, 48 treatment recommendations for gonorrhea and prediction of the efficacy of antimicrobials 49 mainly rely on a single measurement: the MIC of the antimicrobial. However, antimicrobials 50 that have different modes of action and lead to different treatment outcomes can have identical 51 MICs (2) . A better understanding of the in vitro pharmacodynamic properties of antimicrobials 52 could be used to optimize dosing strategies and help prevent treatment failures (3). 53 Regoes et al. (4) introduced the concept of pharmacodynamic functions to study the 54 relationship between bacterial net growth rates and the concentrations of antimicrobials, based 55 on analyses of time-kill curves for a single laboratory strain of Escherichia coli. 56 Mathematically, the pharmacodynamic function is based on a Hill function and characterized 57 by four parameters: the maximal bacterial growth rate in the absence of antimicrobial (ψmax), 58 the minimal bacterial growth rate at high concentrations of antimicrobial (ψmin), the Hill 59 coefficient (к), and the pharmacodynamic MIC (zMIC) ( Figure  1 ). 60 Information about the effects of antimicrobials at concentrations below and above the MIC is 61 particularly valuable for pathogens like N. gonorrhoeae, for which there are limited data about 62 the pharmacokinetic and pharmacodynamic effects of many antimicrobials. Furthermore, the 63 pharmacodynamic properties of novel antimicrobials with known and unknown targets could 64 be evaluated and directly compared to a set of mechanistically well-understood compounds.
kill experiments. The bacterial populations were assumed to grow or die at a constant rate, 141 resulting in an exponential increase or decrease in bacterial density: 142 ( ) = 0 × . 143 The net growth rate was estimated as the coefficient of a linear regression from the logarithm 144 of the colony counts. Maximum likelihood estimation was used to account for the censored data 145 (values below the limit of detection of 100 CFU/ml). The geometric mean of all measurements 7 at zero hours for a given antimicrobial as the first data point, was used. From the growth rate, 147 the bacterial doubling time can be calculated as follows: 148 1/2 = ln (2) . where ψmax is to the maximal bacterial growth rate in the absence of antimicrobial and ψmin is 155 the minimal bacterial net growth rate at high concentrations of antimicrobial. zMIC is the 156 pharmacodynamic MIC where the bacterial growth rate is zero (ψ(zMIC) = 0). к denotes the 157 Hill coefficient, which describes the steepness of the sigmoid relationship between bacterial 158 growth and antimicrobial concentration. For each antimicrobial, four parameters of the 159 pharmacodynamic function were estimated using a self-starter function, implemented in the 160 package drc (13) for the R software environment for statistical computing (14) . All figures can 161 be reproduced with R code and data from the following GitHub repository: 162 https://github.com/sunnivas/PDfunction. 163 
164

RESULTS
165
Growth of N. gonorrhoeae. Growth curves for the five different WHO N. gonorrhoeae 166 reference strains ( Fig. S1 supplemental material) confirmed that growth was well supported in 167 GW medium. All strains could be grown from a starting inoculum of less than 10 3 CFU/ml and 168 had a lag phase of less than five hours. The stationary phase lasted until 36 hours for all strains, 169 8 followed by a steep declination phase. Growth was similar for all strains with WHO L the only 170 strain that had a slightly slower growth. concentrations that are likely to be toxic, so those data points were removed before estimating 200 the parameters of the pharmacodynamic function. 201 The pharmacodynamic functions for the six strains provided information on ciprofloxacin 202 resistance mechanisms ( Fig. 4C and Table S3 in the supplemental material). The DOGK18 203 strain had a low pharmacodynamic MIC (zMIC) and a low net bacterial growth rate at high 204 antimicrobial concentrations (ψmin), indicating the strong bactericidal effect of ciprofloxacin. 205 The five WHO reference strains showed that the ciprofloxacin resistance determinants not only 206 shifted the zMIC but also resulted in less killing at antimicrobial concentrations above the zMIC 207 (higher ψmin compared to DOGK18 strain). 208 The pharmacodynamic functions for the nine antimicrobials in the DOGK18 strain 209 illustrated the different effects that antimicrobials induce on gonococcal growth of N. bactericidal manner should be given as a single high dose (42). This is typically achieved 296 maximizing the AUC/MIC and peak serum concentration/MIC ratio (43-45). Our results 297 suggest that this could be the case for ciprofloxacin, gentamicin and spectinomycin, which were 298 found to be strongly bactericidal. Azithromycin has been described to be bacteriostatic in Table 1 ).
FIG 1
The pharmacodynamics function and four parameters is shown as described in (4). The bacterial growth rates (ψ) in response to each antimicrobial concentration are estimated from time-kill data with linear regression. The maximal bacterial growth rate ψmax, the minimal bacterial net growth rate at high concentrations of antimicrobial ψmin, the pharmacodynamic MIC (zMIC) and the Hill coefficient κ are shown and define the shape of the curve. Table 1 ). 
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